U.S. Marine and Shipping Stock News

NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept Therapeutics (CORT) Stock Could Trade At A Discount As Its 346% Run Looms

Corcept Therapeutics has delivered very strong long term share price gains over the past five years, yet its latest valuation checks lean more cautious, leaving investors weighing a powerful performance track record against a weak overall value score. Corcept Therapeutics is up about 346.1% over five years, which puts the recent share price in the context of a very strong run already behind it. Progress with cortisol modulating drugs, including Lifyorli and the resubmitted relacorilant...
NasdaqGS:VSEC
NasdaqGS:VSECAerospace & Defense

Defense Stocks With Direct Exposure to Energy Security and Military Readiness

Geopolitics just moved back to the front of the market’s attention, with U.S. strikes on Iran, drone and missile attacks across the Gulf, and oil prices reacting sharply. When tensions spill into shipping lanes and supply chains, some stocks can gain new contracts or attention, while others face higher risks and costs. This article looks at how that mix of risk and opportunity connects to the latest Defense and Aerospace Stocks screener and highlights 3 stocks that appear positively exposed...
NYSE:ABT
NYSE:ABTMedical Equipment

Abbott Laboratories (ABT) Stock Faces Margin Squeeze As Net Profit Slide Tests Growth Narrative

Abbott Laboratories (ABT) just posted Q2 2026 revenue of about US$12.6b with basic EPS of US$0.53, alongside trailing twelve month revenue of roughly US$46.6b and EPS of US$3.11. Over recent quarters the company has seen revenue move from about US$11.1b in Q2 2025 to US$12.6b in Q2 2026, while quarterly EPS shifted from US$1.02 to US$0.53. This sets up a results season where investors are likely to focus closely on how margins are holding up in the current mix of growth drivers. See our full...
NYSE:KEX
NYSE:KEXShipping

Kirby (KEX) Draws Interest As Tight Barge Supply Supports A Fair Value Gap

AI trading signals put Kirby in focus Fresh AI generated trading signals around Kirby (KEX) have pushed the stock into the spotlight, with the models flagging neutral near and mid term readings, as well as a long term strong positive bias. The same signals highlight a mid channel oscillation pattern and outline a short setup with defined downside potential and limited indicated risk, along with suggested institutional style long, breakout, and hedging approaches. See our latest analysis for...
NYSE:OSCR
NYSE:OSCRInsurance

Oscar Health (OSCR) Could Be 29% Above Fair Value After Zacks Rank Upgrade

Oscar Health (OSCR) is back in focus after recent analyst reports cited substantial upward revisions in earnings estimates and a top Zacks Rank #1 rating, prompting fresh attention from both value and momentum investors. See our latest analysis for Oscar Health. The recent attention on Oscar Health has come alongside a sharp swing in momentum, with a 1-day share price return of 0.83% and a 7-day share price return down 4.72%, set against a 90-day share price return of 84.29% and a 1-year...
NasdaqGS:ECHO
NasdaqGS:ECHOMedia

EchoStar (ECHO) CEO Exit Hands Charles Ergen And Thomas Cullen The Lead

EchoStar CEO Hamid Akhavan has resigned, with leadership duties moving to Charles W. Ergen and Thomas A. Cullen. The change comes alongside a shift in EchoStar's strategic direction affecting how key business units are run. Investors are assessing what the new leadership structure could mean for culture, execution, and the company’s future focus. EchoStar, traded as NasdaqGS:ECHO, is entering a transition period at a time when its share price sits at $92.0. The stock is down 4.2% over the...
NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

Intuitive Surgical (ISRG) Stock Highlights 20% EPS Growth Reinforcing Bullish Profitability Narratives

Intuitive Surgical (ISRG) has released its Q2 2026 numbers, with revenue of US$2.9 billion and basic EPS of US$2.31, set against trailing 12 month revenue of US$11.0 billion and EPS of US$8.84. Over recent quarters, the company has seen revenue move from US$2.44 billion in Q2 2025 to US$2.89 billion in Q2 2026, while quarterly EPS shifted from US$1.84 to US$2.31, with trailing earnings up 20.4% over the past year and 16.7% per year over the past five years. With a net profit margin of 28.4%...
NYSE:AGM
NYSE:AGMDiversified Financial

Is Federal Agricultural Mortgage (AGM) Priced For Fair Value Or More?

Federal Agricultural Mortgage stock has delivered strong long term gains for shareholders over the past five years, yet the latest valuation work suggests the current share price may still sit below an intrinsic value estimate based on the Excess Returns model. At the same time, traditional earnings multiples look roughly in line with peers, which raises the question of whether the recent share price level around US$205.50 already reflects most of the good news. Federal Agricultural Mortgage...
NYSE:ARW
NYSE:ARWElectronic

Arrow Electronics (ARW) Stock Looks Discounted To Fair Value Despite Mixed Broader Checks

Arrow Electronics has surged 82.8% year to date. After that kind of run, the key issue for investors is whether the stock’s current valuation still leaves a reasonable margin of safety or is starting to price in a lot of good news upfront. The 82.8% gain year to date suggests expectations around Arrow Electronics have shifted sharply higher, and the stock is now priced for continued delivery rather than a simple recovery story. Recent AI driven growth in components for data centers and...
NasdaqGS:ONB
NasdaqGS:ONBBanks

Is Old National Bancorp (ONB) Still Cheap Relative To Fair Value?

Old National Bancorp stock has nearly doubled investors' money over the past five years, yet current valuation work suggests the shares may still trade below an intrinsic value estimate built on the Excess Returns model. This puts recent gains and the pricing signal at odds. Around 94.2% total return over five years points to Old National Bancorp having been a strong compounder for long term holders, which naturally raises the question of how much value is already reflected in the price. For...
NYSE:PRIM
NYSE:PRIMConstruction

Primoris (PRIM) Stock May Be Below Fair Value Despite Strong Backlog Growth

Primoris Services has delivered a strong 210.3% total return over the past five years, yet its current valuation screens as cheap, with both a Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples suggesting the stock trades at a discount to what the business may be worth. Over five years, Primoris Services has returned 210.3%, which puts recent share price weakness in the context of a strong longer term run. Recent coverage highlighting revenue growth, backlog expansion...
NasdaqCM:FRHC
NasdaqCM:FRHCCapital Markets

Does Freedom Holding (FRHC) Pair Its $300 Million Equity Raise With Stronger Governance Or New Risks?

Freedom Holding Corp. recently completed a US$300,000,000 follow-on equity offering under Regulation S, issuing 2,374,356 common shares at US$126.35005 each, and also announced the resignation of board member Kairat Kelimbetov, effective July 8, 2026. The combination of a sizable capital raise and a reduction in board size highlights an important moment for how Freedom Holding balances governance and growth-oriented funding decisions. We will now examine how the US$300,000,000 follow-on...
NYSE:DAN
NYSE:DANAuto Components

Dana (DAN) To Acquire Eaton Mobility Group In Reverse Morris Trust Deal

Dana Inc. (NYSE:DAN) announced it will acquire Eaton's Mobility Group through a Reverse Morris Trust transaction. The deal involves creating a new entity that will merge with Dana, with the transaction supported by bridge financing. The acquisition is positioned to increase Dana's margins and aftermarket exposure, affecting its long-term business mix. Dana is a global supplier of power conveyance and energy management solutions for vehicles and machinery. The planned Eaton Mobility Group...
NYSE:BE
NYSE:BEElectrical

Bloom Energy (BE) Lands $1.7 Billion Nebius AI Fuel Cell Backing

IDF and Oaktree have committed $1.7b to deploy Bloom Energy fuel cells for Nebius' AI infrastructure build out. The capital will fund dedicated on site power for Nebius data centers focused on AI workloads. The project highlights third party investors directly backing Bloom Energy's technology for AI data center power needs. Bloom Energy (NYSE:BE) is drawing fresh attention after Industrial Development Funding and Oaktree agreed to a $1.7b fuel cell deployment for Nebius' AI cloud build...
NYSE:KMX
NYSE:KMXSpecialty Retail

CarMax (KMX) Is Up 7.2% After Earnings Beat And Governance Probe News - What's Changed

In recent weeks, CarMax reported quarterly earnings that exceeded analyst expectations, with higher-than-forecast revenue supported by robust wholesale vehicle sales despite retail pressures. At the same time, law firm Bernstein Liebhard LLP began investigating potential fiduciary duty breaches by certain CarMax directors and officers affecting shareholders who bought before June 20, 2025, adding a governance angle to the company’s improving operational story. With CarMax’s earnings beat...
NYSE:AAT
NYSE:AATREITs

American Assets Trust (AAT) Stock Looks Pricey On Its 40% Run

American Assets Trust stock has climbed over the last few years and recently touched a new 52 week high, yet its valuation checks and market multiples suggest the shares may no longer be an obvious bargain, even though the Discounted Cash Flow (DCF) estimate points to a roughly fair price relative to the current level. Over the past 3 years, American Assets Trust has returned 39.7%, which puts recent valuation questions front and center after a solid run. Investor sentiment has been...
NYSE:MAA
NYSE:MAAResidential REITs

Did SouthPark Mixed-Use Rezoning Just Shift Mid-America Apartment Communities' (MAA) Investment Narrative?

Mid-America Apartment Communities has filed a rezoning petition for the former Phillips Place Regal Cinemas site in SouthPark, aiming to build a 275-unit apartment community with 15,000 square feet of commercial space, marking a new mixed-use investment in the area. This project highlights MAA’s ongoing push to expand its footprint in high-demand Sun Belt-adjacent markets through higher-density, mixed-use development. We’ll now examine how this planned 275-unit SouthPark development could...
NYSE:RXO
NYSE:RXOTransportation

Is RXO (RXO) Turning Cargo Security Into a Durable Edge in Freight Brokerage?

On 14 July 2026, RXO Inc. announced a partnership with Highway Inc. to integrate advanced Carrier Identity, fraud prevention, and Load Lock+ ELD real-time tracking into its brokerage network, aiming to improve security, carrier verification speed, and shipment visibility. This move deepens RXO’s identity-driven defense against threats such as chameleon carriers and double brokering, building on recent industry recognition from CargoNet’s “Best in Cargo Security” award and the FreightWaves...
NYSE:CL
NYSE:CLHousehold Products

Consumer Staples Stocks for Defensive Income as Inflation Eases

With US inflation easing to 3.5% and gas prices pulling headline figures lower, investors are again weighing how persistent high living costs might affect essential spending. Consumer staples stocks sit at the center of that debate, as households still need food and household goods even when budgets feel tight. This article looks at 3 stocks from a Consumer Staples Stocks screener that appear closely exposed to the latest inflation news. Each company may react differently to easing price...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx Pharmaceutical (RARE) On Rare Disease Growth Narrative And Why Valuation Is Back In Focus

Ultragenyx Pharmaceutical (RARE) stock continues to trade with recent moves shaped largely by its rare disease portfolio and late stage pipeline. This has prompted investors to reassess risk, growth potential, and current valuation. See our latest analysis for Ultragenyx Pharmaceutical. At a share price of $29.28, Ultragenyx Pharmaceutical has seen short term pressure, with a 1 day share price return down 3.11% and 7 day share price return down 13.42%. This is set against a 90 day share price...
NYSE:DG
NYSE:DGConsumer Retailing

Dollar General (DG) Stock May Be 27% Undervalued Despite Raised Guidance

Dollar General stock has delivered a steep 40.3% decline over the past 5 years, yet current valuation checks and intrinsic value work both suggest the shares now trade at a discount to what the underlying business may be worth. Over 5 years, Dollar General shareholders are down 40.3%, which sets expectations for a potential reset in how the stock is priced relative to its fundamentals. Rising gas prices and household cost pressures can support revenue as consumers trade down to discount...
NYSE:HAE
NYSE:HAEMedical Equipment

Haemonetics (HAE) Could Be 10% Undervalued On Its Margin Expansion Story

Haemonetics (HAE) has drawn attention after recent share price moves, including a gain of about 7% over the past month and roughly 26% over the past 3 months. These changes are prompting closer examination of its fundamentals. See our latest analysis for Haemonetics. At a share price of $77.86, Haemonetics shows recent momentum with a 30 day share price return of 7.05% and a 90 day share price return of 26.36%. This is set against a more modest 1 year total shareholder return of 7.32% and a 3...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Halozyme Therapeutics (HALO) Gets A Lift As Darzalex Faspro Trial Improves Survival

Partner trial for Darzalex Faspro using Halozyme's ENHANZE technology reported significant survival benefits for multiple myeloma patients. Late stage study results point to improved outcomes for people receiving this subcutaneous therapy. News is material for Halozyme Therapeutics (NasdaqGS:HALO) as it relates directly to one of its key partnered medicines. Halozyme Therapeutics centers its business on ENHANZE, a drug delivery technology licensed to large biopharma partners. The latest...
NasdaqGS:VC
NasdaqGS:VCAuto Components

Visteon (VC) Secures Multi Year Memory Supply Deals For AI Ready Vehicles

Visteon (NasdaqGS:VC) has entered new multi year partnership agreements to secure advanced memory and storage supplies for automotive applications. The company is part of Micron's newly completed Strategic Customer Agreements alongside other major automotive suppliers and partners. The partnerships focus on long term supply and technology planning for next generation, AI enabled vehicle platforms. Visteon sits at the intersection of automotive electronics and software, supplying cockpit...